Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Vincent, JL
   Microvascular endothelial dysfunction: a renewed appreciation of sepsis pathophysiology
   CRITICAL CARE
   
   J.L. Vincent, "Microvascular endothelial dysfunction: a renewed appreciation of sepsis pathophysiology", CRIT CARE, 5, 2001, pp. S1-S5
2. Isnard, R; Komajda, M
   Thromboembolism in heart failure, old ideas and new challenges
   EUROPEAN JOURNAL OF HEART FAILURE
   
   R. Isnard e M. Komajda, "Thromboembolism in heart failure, old ideas and new challenges", EUR J HE FA, 3(3), 2001, pp. 265-269
3. Coburn, CA
   Small-molecule direct thrombin inhibitors: 1997-2000
   EXPERT OPINION ON THERAPEUTIC PATENTS
   
   C.A. Coburn, "Small-molecule direct thrombin inhibitors: 1997-2000", EXPERT OP T, 11(5), 2001, pp. 721-738
4. Yermiahu, T; Arbelle, JE; Shwartz, D; Levy, Y; Tractinsky, N; Porath, A
   Quality assessment of oval anticoagulant treatment in the Beer-Sheba district
   INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE
   
   T. Yermiahu et al., "Quality assessment of oval anticoagulant treatment in the Beer-Sheba district", INT J QUAL, 13(3), 2001, pp. 209-213
5. Yoneda, Y; Mori, E; Uehara, T; Yamada, O; Tabuchi, M
   Referral and care for acute ischemic stroke in a Japanese tertiary emergency hospital
   EUROPEAN JOURNAL OF NEUROLOGY
   
   Y. Yoneda et al., "Referral and care for acute ischemic stroke in a Japanese tertiary emergency hospital", EUR J NEUR, 8(5), 2001, pp. 483-488
6. Rukshin, V; Azarbal, B; Shah, PK; Tsang, VT; Shechter, M; Finkelstein, A; Cercek, B; Kaul, S
   Intravenous magnesium in experimental stent thrombosis in swine
   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
   
   V. Rukshin et al., "Intravenous magnesium in experimental stent thrombosis in swine", ART THROM V, 21(9), 2001, pp. 1544-1549
7. Arosio, E; Ferrari, G; Santoro, L; Gianese, F; Coccheri, S
   A placebo-controlled, double-blind study of mesoglycan in the treatment ofchronic venous ulcers
   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
   
   E. Arosio et al., "A placebo-controlled, double-blind study of mesoglycan in the treatment ofchronic venous ulcers", EUR J VAS E, 22(4), 2001, pp. 365-372
8. Haas, S
   Prevention of venous thromboembolism: Recommendations based on the International Consensus and the American College of Chest Physicians Sixth Consensus Conference on Antithrombotic Therapy
   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
   
   S. Haas, "Prevention of venous thromboembolism: Recommendations based on the International Consensus and the American College of Chest Physicians Sixth Consensus Conference on Antithrombotic Therapy", CL APPL T-H, 7(3), 2001, pp. 171-177
9. Van Aken, H; Bode, C; Darius, H; Diehm, C; Encke, M; Gulba, DC; Haas, S; Hacke, W; Puhl, W; Quante, M; Riess, H; Scharf, R; Schellong, S; Schror, K; Schulte, KL; Tebbe, U
   Anticoagulation: The present and future
   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
   
   H. Van Aken et al., "Anticoagulation: The present and future", CL APPL T-H, 7(3), 2001, pp. 195-204
10. Demir, M; Iqbal, O; Hoppensteadt, DA; Piccolo, P; Ahmad, S; Schultz, CL; Linhardt, RJ; Fareed, J
    Anticoagulant and antiprotease profiles of a novel natural heparinomimeticmannopentaose phosphate sulfate (PI-88)
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    
    M. Demir et al., "Anticoagulant and antiprotease profiles of a novel natural heparinomimeticmannopentaose phosphate sulfate (PI-88)", CL APPL T-H, 7(2), 2001, pp. 131-140
11. Devuyst, G; Bogousslavsky, J
    Recent progress in drug treatment for acute ischemic stroke
    CEREBROVASCULAR DISEASES
    
    G. Devuyst e J. Bogousslavsky, "Recent progress in drug treatment for acute ischemic stroke", CEREB DIS, 11, 2001, pp. 71-79
12. Grubitzsch, H; Wollert, HG; Eckel, L
    Emergency coronary artery bypass grafting: does excessive preoperative anticoagulation increase bleeding complications and transfusion requirements?
    CARDIOVASCULAR SURGERY
    
    H. Grubitzsch et al., "Emergency coronary artery bypass grafting: does excessive preoperative anticoagulation increase bleeding complications and transfusion requirements?", CARDIOV SUR, 9(5), 2001, pp. 510-516
13. Dudley, N
    Importance of risk communication and decision making in cardiovascular conditions in older patients: a discussion paper
    QUALITY IN HEALTH CARE
    
    N. Dudley, "Importance of risk communication and decision making in cardiovascular conditions in older patients: a discussion paper", QUAL HEAL C, 10, 2001, pp. I19-I22
14. Taylor, FC; Cohen, H; Ebrahim, S
    Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation
    BRITISH MEDICAL JOURNAL
    
    F.C. Taylor et al., "Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation", BR MED J, 322(7282), 2001, pp. 321-326
15. Becker, RC
    Anticoagulation and the heart
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    
    R.C. Becker, "Anticoagulation and the heart", J THROMB TH, 12(1), 2001, pp. 41-52
16. Choi, HS; Sa, YS
    Fibrinolytic and antithrombotic protease from Spirodela polyrhiza
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
    
    H.S. Choi e Y.S. Sa, "Fibrinolytic and antithrombotic protease from Spirodela polyrhiza", BIOS BIOT B, 65(4), 2001, pp. 781-786
17. Huber, TS; Seeger, JM
    Contribution of the Southern Association for Vascular Surgery to the scientific literature
    JOURNAL OF VASCULAR SURGERY
    
    T.S. Huber e J.M. Seeger, "Contribution of the Southern Association for Vascular Surgery to the scientific literature", J VASC SURG, 34(3), 2001, pp. 393-396
18. Klein, AL; Murray, RD; Grimm, RA
    Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    A.L. Klein et al., "Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation", J AM COL C, 37(3), 2001, pp. 691-704
19. Chugh, SS; Blackshear, JL; Shen, WK; Hammill, SC; Gersh, BJ
    Epidemiology and natural history of atrial fibrillation: Clinical implications
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    S.S. Chugh et al., "Epidemiology and natural history of atrial fibrillation: Clinical implications", J AM COL C, 37(2), 2001, pp. 371-378
20. Jakobs, D
    Heparin-induced thrombocytopenia, left ventricular thrombus and cerebral embolism in the course of myocardial infarction
    MEDIZINISCHE KLINIK
    
    D. Jakobs, "Heparin-induced thrombocytopenia, left ventricular thrombus and cerebral embolism in the course of myocardial infarction", MED KLIN, 96(2), 2001, pp. 101-104
21. Momi, S; Nasimi, M; Colucci, M; Nenci, GP; Gresele, P
    Low molecular weight heparins prevent thrombin-induced thromboembolism in mice despite low antithrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition
    HAEMATOLOGICA
    
    S. Momi et al., "Low molecular weight heparins prevent thrombin-induced thromboembolism in mice despite low antithrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition", HAEMATOLOG, 86(3), 2001, pp. 297-302
22. Mulrow, CD; Lohr, KN
    Proof and policy from medical research evidence
    JOURNAL OF HEALTH POLITICS POLICY AND LAW
    
    C.D. Mulrow e K.N. Lohr, "Proof and policy from medical research evidence", J HEALTH P, 26(2), 2001, pp. 249-266
23. Schellong, SM; Ockert, D; Hanig, V
    Acute limb ischemia
    HERZ
    
    S.M. Schellong et al., "Acute limb ischemia", HERZ, 26, 2001, pp. 61-68
24. Nenci, GG; Gresele, P; Ferrari, G; Santoro, L; Gianese, F
    Treatment of intermittent claudication with mesoglycan - A placebo-controlled, double-blind study
    THROMBOSIS AND HAEMOSTASIS
    
    G.G. Nenci et al., "Treatment of intermittent claudication with mesoglycan - A placebo-controlled, double-blind study", THROMB HAEM, 86(5), 2001, pp. 1181-1187
25. Vicente, CP; Zancan, P; Peixoto, LL; Alves-Sa, R; Araujo, FS; Mourao, PAS; Pavao, MSG
    Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding
    THROMBOSIS AND HAEMOSTASIS
    
    C.P. Vicente et al., "Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding", THROMB HAEM, 86(5), 2001, pp. 1215-1220
26. Jirouskova, M; Smyth, SS; Kudryk, B; Coller, BS
    A hamster antibody to the mouse fibrinogen gamma chain inhibits platelet-fibrinogen interactions and FXIIIa-mediated fibrin cross-linking, and facilitates thrombolysis
    THROMBOSIS AND HAEMOSTASIS
    
    M. Jirouskova et al., "A hamster antibody to the mouse fibrinogen gamma chain inhibits platelet-fibrinogen interactions and FXIIIa-mediated fibrin cross-linking, and facilitates thrombolysis", THROMB HAEM, 86(4), 2001, pp. 1047-1056
27. Coller, BS
    Anti-GPIIb/IIIa drugs: Current strategies and future directions
    THROMBOSIS AND HAEMOSTASIS
    
    B.S. Coller, "Anti-GPIIb/IIIa drugs: Current strategies and future directions", THROMB HAEM, 86(1), 2001, pp. 427-443
28. Himber, J; Refino, CJ; Burcklen, L; Roux, S; Kirchhofer, D
    Inhibition of arterial thrombosis by a soluble tissue factor mutant and active site-blocked factors IXa and Xa in the guinea pig
    THROMBOSIS AND HAEMOSTASIS
    
    J. Himber et al., "Inhibition of arterial thrombosis by a soluble tissue factor mutant and active site-blocked factors IXa and Xa in the guinea pig", THROMB HAEM, 85(3), 2001, pp. 475-481
29. Jouault, SC; Chevolot, L; Helley, D; Ratiskol, J; Bros, A; Sinquin, C; Roger, O; Fischer, AM
    Characterization, chemical modifications and in vitro anticoagulant properties of an exopolysaccharide produced by Alteromonas infernus
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
    
    S.C. Jouault et al., "Characterization, chemical modifications and in vitro anticoagulant properties of an exopolysaccharide produced by Alteromonas infernus", BBA-GEN SUB, 1528(2-3), 2001, pp. 141-151
30. van Hinsbergh, VWM
    The endothelium: vascular control of haemostasis
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
    
    V.W.M. van Hinsbergh, "The endothelium: vascular control of haemostasis", EUR J OB GY, 95(2), 2001, pp. 198-201
31. Mueller-Kolck, U
    Long-term oral anticoagulation therapy of peripheral arterial disease
    VASA-JOURNAL OF VASCULAR DISEASES
    
    U. Mueller-Kolck, "Long-term oral anticoagulation therapy of peripheral arterial disease", VASA, 30(2), 2001, pp. 83-88
32. Pineo, GF
    New developments in the prevention and treatment of venous thromboembolism
    PHARMACOTHERAPY
    
    G.F. Pineo, "New developments in the prevention and treatment of venous thromboembolism", PHARMACOTHE, 21(6), 2001, pp. 51S-55S
33. Wiesholzer, M; Harm, F; Tomasec, G; Barbieri, G; Putz, D; Balcke, P
    Incidence of stroke among chronic hemodialysis patients with nonrheumatic atrial fibrillation
    AMERICAN JOURNAL OF NEPHROLOGY
    
    M. Wiesholzer et al., "Incidence of stroke among chronic hemodialysis patients with nonrheumatic atrial fibrillation", AM J NEPHR, 21(1), 2001, pp. 35-39
34. Nicholson, NS; Abood, NA; Panzer-Knodle, SG; Frederick, LG; Page, JD; Salyers, AK; Suleymanov, OD; Szalony, JA; Taite, BB; Anders, RJ
    Orbofiban: An orally active GPIIB/IIIa platelet receptor antagonist
    MEDICINAL RESEARCH REVIEWS
    
    N.S. Nicholson et al., "Orbofiban: An orally active GPIIB/IIIa platelet receptor antagonist", MED RES REV, 21(3), 2001, pp. 211-226
35. Coussement, PK; Bassand, JP; Convens, C; Vrolix, M; Boland, J; Grollier, G; Michels, R; Vahanian, A; Vanderheyden, M; Rupprecht, HJ; Van de Werf, F
    A synthetic factor-Xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction - The PENTALYSE study
    EUROPEAN HEART JOURNAL
    
    P.K. Coussement et al., "A synthetic factor-Xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction - The PENTALYSE study", EUR HEART J, 22(18), 2001, pp. 1716-1724
36. Husted, S; Becker, R; Kher, A
    A critical review of clinical trials for low-molecular-weight heparin therapy in unstable coronary artery disease
    CLINICAL CARDIOLOGY
    
    S. Husted et al., "A critical review of clinical trials for low-molecular-weight heparin therapy in unstable coronary artery disease", CLIN CARD, 24(7), 2001, pp. 492-499
37. Kamath, S; Lip, GYH
    Targeting patients with atrial fibrillation and improving their anticoagulation management
    CLINICAL CARDIOLOGY
    
    S. Kamath e G.Y.H. Lip, "Targeting patients with atrial fibrillation and improving their anticoagulation management", CLIN CARD, 24(5), 2001, pp. 355-357
38. Cohen, N; Almoznino-Sarafian, D; Alon, I; Gorelik, O; Koopfer, M; Chachashvily, S; Shteinshnaider, M; Litvinjuk, V; Modai, D
    Adequacy of anticoagulation in patients with atrial fibrillation: Effect of various parameters
    CLINICAL CARDIOLOGY
    
    N. Cohen et al., "Adequacy of anticoagulation in patients with atrial fibrillation: Effect of various parameters", CLIN CARD, 24(5), 2001, pp. 380-384
39. Nader, HB; Pinhal, MAS; Bau, EC; Castro, RAB; Medeiros, GF; Chavante, SF; Leite, EL; Trindade, ES; Shinjo, SK; Rocha, HAO; Tersariol, ILS; Mendes, A; Dietrich, CP
    Development of new heparin-like compounds and other antithrombotic drugs and their interaction with vascular endothelial cells
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    
    H.B. Nader et al., "Development of new heparin-like compounds and other antithrombotic drugs and their interaction with vascular endothelial cells", BRAZ J MED, 34(6), 2001, pp. 699-709
40. Gage, BF; Waterman, AD; Shannon, W; Boechler, M; Rich, MW; Radford, MJ
    Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    
    B.F. Gage et al., "Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation", J AM MED A, 285(22), 2001, pp. 2864-2870
41. Sanderson, PEJ
    Chapter 8. Anticoagulants: Inhibitors of thrombin and factor Xa
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 36
    
    P.E.J. Sanderson, "Chapter 8. Anticoagulants: Inhibitors of thrombin and factor Xa", ANNU REP M, 36, 2001, pp. 79-88
42. Yun-Choi, HS; Pyo, MK; Park, KM; Chang, KC; Lee, DH
    Antithrombotic effects of YS-49 and YS-51-1-naphthylmethyl analogs of higenamine
    THROMBOSIS RESEARCH
    
    H.S. Yun-Choi et al., "Antithrombotic effects of YS-49 and YS-51-1-naphthylmethyl analogs of higenamine", THROMB RES, 104(4), 2001, pp. 249-255
43. Damiano, BP; Mitchell, JA; Giardino, E; Corcoran, T; Haertlein, BJ; de Garavilla, L; Kauffman, JA; Hoekstra, WJ; Maryanoff, BE; Andrade-Gordon, P
    Antiplatelet and antithrombotic activity of RWJ-53308, a novel orally active glycoprotein IIb/IIIa antagonist
    THROMBOSIS RESEARCH
    
    B.P. Damiano et al., "Antiplatelet and antithrombotic activity of RWJ-53308, a novel orally active glycoprotein IIb/IIIa antagonist", THROMB RES, 104(2), 2001, pp. 113-126
44. Chu, V; Brown, K; Colussi, D; Gao, JB; Bostwick, J; Kasiewski, C; Bentley, R; Morgan, S; Guertin, K; Pauls, HW; Gong, Y; Zulli, A; Perrone, MH; Dunwiddie, CT; Leadley, RJ
    Pharmacological characterization of a novel factor Xa inhibitor, FXV673
    THROMBOSIS RESEARCH
    
    V. Chu et al., "Pharmacological characterization of a novel factor Xa inhibitor, FXV673", THROMB RES, 103(4), 2001, pp. 309-324
45. Wall, D; Douglas, S; Ferro, V; Cowden, W; Parish, C
    Characterisation of the anticoagulant properties of a range of structurally diverse sulfated oligosaccharides
    THROMBOSIS RESEARCH
    
    D. Wall et al., "Characterisation of the anticoagulant properties of a range of structurally diverse sulfated oligosaccharides", THROMB RES, 103(4), 2001, pp. 325-335
46. Sappok, T; Faulstich, A; Stuckert, E; Kruck, H; Marx, P; Koennecke, HC
    Compliance with secondary prevention of ischemic stroke - A prospective evaluation
    STROKE
    
    T. Sappok et al., "Compliance with secondary prevention of ischemic stroke - A prospective evaluation", STROKE, 32(8), 2001, pp. 1884-1889
47. Wehinger, C; Stollberger, C; Langer, T; Schneider, B; Finsterer, J
    Evaluation of risk factors for stroke/embolism and of complications due toanticoagulant therapy in atrial fibrillation
    STROKE
    
    C. Wehinger et al., "Evaluation of risk factors for stroke/embolism and of complications due toanticoagulant therapy in atrial fibrillation", STROKE, 32(10), 2001, pp. 2246-2252
48. Turpie, AGG
    Looking forward in the treatment of deep-vein thrombosis
    SEMINARS IN HEMATOLOGY
    
    A.G.G. Turpie, "Looking forward in the treatment of deep-vein thrombosis", SEM HEMATOL, 38(2), 2001, pp. 49-57
49. Faaij, RA; van Griensven, JMT; Schoemaker, RC; Goggin, T; Guenzi, A; Kroon, JM; Burggraaf, J; Cohen, AF
    The effect of warfarin on the pharmacokinetics and pharmacodynamics of napsagatran in healthy male volunteers
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    
    R.A. Faaij et al., "The effect of warfarin on the pharmacokinetics and pharmacodynamics of napsagatran in healthy male volunteers", EUR J CL PH, 57(1), 2001, pp. 25-29
50. Hankey, GJ
    Non-valvular atrial fibrillation and stroke prevention
    MEDICAL JOURNAL OF AUSTRALIA
    
    G.J. Hankey, "Non-valvular atrial fibrillation and stroke prevention", MED J AUST, 174(5), 2001, pp. 234-239
51. Perepetch, NB; Nesterova, IV
    Assessment of antianginal and antiischemic efficacy of sulodexide as a component of combination pharmacotherapy of high functional class angina
    KARDIOLOGIYA
    
    N.B. Perepetch e I.V. Nesterova, "Assessment of antianginal and antiischemic efficacy of sulodexide as a component of combination pharmacotherapy of high functional class angina", KARDIOLOGIY, 41(1), 2001, pp. 16-20
52. Thibault, G; Tardif, P; Lapalme, G
    Comparative specificity of platelet alpha(IIb)beta(3) integrin antagonists
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    G. Thibault et al., "Comparative specificity of platelet alpha(IIb)beta(3) integrin antagonists", J PHARM EXP, 296(3), 2001, pp. 690-696
53. Stilz, HU; Guba, W; Jablonka, B; Just, M; Klingler, O; Konig, W; Wehner, V; Zoller, G
    Discovery of an orally active non-peptide fibrinogen receptor antagonist based on the hydantoin scaffold
    JOURNAL OF MEDICINAL CHEMISTRY
    
    H.U. Stilz et al., "Discovery of an orally active non-peptide fibrinogen receptor antagonist based on the hydantoin scaffold", J MED CHEM, 44(8), 2001, pp. 1158-1176
54. Liem, LK; Choong, LHL; Woo, KT
    Action of dipyridamole and warfarin on growth of human endothelial cells cultured in serum-free media
    CLINICAL BIOCHEMISTRY
    
    L.K. Liem et al., "Action of dipyridamole and warfarin on growth of human endothelial cells cultured in serum-free media", CLIN BIOCH, 34(2), 2001, pp. 141-147
55. Galvani, M; Ferrini, D; Ghezzi, F; Ottani, F
    Cardiac markers and risk stratification: an integrated approach
    CLINICA CHIMICA ACTA
    
    M. Galvani et al., "Cardiac markers and risk stratification: an integrated approach", CLIN CHIM A, 311(1), 2001, pp. 9-17
56. Lindahl, B
    Markers of myocardial damage in acute coronary syndromes - therapeutic implications
    CLINICA CHIMICA ACTA
    
    B. Lindahl, "Markers of myocardial damage in acute coronary syndromes - therapeutic implications", CLIN CHIM A, 311(1), 2001, pp. 27-32
57. Ottani, F; Galvani, M
    Prognostic role of hemostatic markers in acute coronary syndromes patients
    CLINICA CHIMICA ACTA
    
    F. Ottani e M. Galvani, "Prognostic role of hemostatic markers in acute coronary syndromes patients", CLIN CHIM A, 311(1), 2001, pp. 33-39
58. Bhatt, DL; Chew, DP; Hirsch, AT; Ringleb, PA; Hacke, W; Topol, EJ
    Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery
    CIRCULATION
    
    D.L. Bhatt et al., "Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery", CIRCULATION, 103(3), 2001, pp. 363-368
59. Nagashima, S; Akamatsu, S; Kawaminami, E; Kawazoe, S; Ogami, T; Matsumoto, Y; Okada, M; Suzuki, KI; Tsukamoto, SI
    Novel malonamide derivatives as alpha(v)beta(3) antagonists. Syntheses andevaluation of 3-(3-indolin-1-yl-3-oxopropanoyl)aminopropanoic acids on vitronectin interaction with alpha(v)beta(3)
    CHEMICAL & PHARMACEUTICAL BULLETIN
    
    S. Nagashima et al., "Novel malonamide derivatives as alpha(v)beta(3) antagonists. Syntheses andevaluation of 3-(3-indolin-1-yl-3-oxopropanoyl)aminopropanoic acids on vitronectin interaction with alpha(v)beta(3)", CHEM PHARM, 49(11), 2001, pp. 1420-1432
60. Nishida, H; Miyazaki, Y; Kitamura, Y; Ohashi, M; Matsusue, T; Okamoto, A; Hosaka, Y; Ohnishi, S; Mochizuki, H
    Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitor
    CHEMICAL & PHARMACEUTICAL BULLETIN
    
    H. Nishida et al., "Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitor", CHEM PHARM, 49(10), 2001, pp. 1237-1244
61. Bozo, E; Boros, S; Kuszmann, J
    Orally active antithrombotic thioglycosides, Part XIII - Conversion of 2,6-anhydro-D-altrose and -mannose derivatives with 4-substituted phenyl thiols to prepare compounds with potential antithrombotic activity
    CARBOHYDRATE RESEARCH
    
    E. Bozo et al., "Orally active antithrombotic thioglycosides, Part XIII - Conversion of 2,6-anhydro-D-altrose and -mannose derivatives with 4-substituted phenyl thiols to prepare compounds with potential antithrombotic activity", CARBOHY RES, 332(3), 2001, pp. 325-333
62. Mousa, SA; Bozarth, JM; Naik, UP; Slee, A
    Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetic:distinct binding profile for Roxifiban
    BRITISH JOURNAL OF PHARMACOLOGY
    
    S.A. Mousa et al., "Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetic:distinct binding profile for Roxifiban", BR J PHARM, 133(3), 2001, pp. 331-336
63. Zhao, BQ; Suzuki, Y; Kondo, K; Kawano, K; Ikeda, Y; Umemura, K
    Cerebral hemorrhage due to heparin limits its neuroprotective effects: studies in a rabbit model of photothrombotic middle cerebral artery occlusion
    BRAIN RESEARCH
    
    B.Q. Zhao et al., "Cerebral hemorrhage due to heparin limits its neuroprotective effects: studies in a rabbit model of photothrombotic middle cerebral artery occlusion", BRAIN RES, 902(1), 2001, pp. 30-39
64. McCormick, D; Gurwitz, JH; Goldberg, RJ; Becker, R; Tate, JP; Elwell, A; Radford, MJ
    Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting
    ARCHIVES OF INTERNAL MEDICINE
    
    D. McCormick et al., "Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting", ARCH IN MED, 161(20), 2001, pp. 2458-2463
65. Gage, BF; Fihn, SD; White, RH
    Warfarin therapy for an octogenarian who has atrial fibrillation
    ANNALS OF INTERNAL MEDICINE
    
    B.F. Gage et al., "Warfarin therapy for an octogenarian who has atrial fibrillation", ANN INT MED, 134(6), 2001, pp. 465-474
66. Samama, CM; Thiry, D; Elalamy, I; Diaby, M; Guillosson, JJ; Kieffer, E; Coriat, P
    Perioperative activation of hemostasis in vascular surgery patients
    ANESTHESIOLOGY
    
    C.M. Samama et al., "Perioperative activation of hemostasis in vascular surgery patients", ANESTHESIOL, 94(1), 2001, pp. 74-78
67. Van de Werf, F
    New data in treatment of acute coronary syndromes
    AMERICAN HEART JOURNAL
    
    F. Van de Werf, "New data in treatment of acute coronary syndromes", AM HEART J, 142(2), 2001, pp. S16-S21
68. Santopinto, J; Gurfinkel, EP; Torres, V; Marcos, E; Bozovich, GE; Mautner, B; McCabe, CH; Antman, EM
    Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin
    AMERICAN HEART JOURNAL
    
    J. Santopinto et al., "Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin", AM HEART J, 141(4), 2001, pp. 566-572
69. Richardson, P; Guinan, E
    Hepatic veno-occlusive disease following hematopoietic stem cell transplantation
    ACTA HAEMATOLOGICA
    
    P. Richardson e E. Guinan, "Hepatic veno-occlusive disease following hematopoietic stem cell transplantation", ACT HAEMAT, 106(1-2), 2001, pp. 57-68
70. Supuran, CT; Briganti, F; Scozzafava, A; Ilies, MA
    Protease inhibitors: Part 4. Synthesis of weakly basic thrombin inhibitorsincorporating pyridinium-sulfanilylaminoguanidine moieties
    JOURNAL OF ENZYME INHIBITION
    
    C.T. Supuran et al., "Protease inhibitors: Part 4. Synthesis of weakly basic thrombin inhibitorsincorporating pyridinium-sulfanilylaminoguanidine moieties", J ENZ INHIB, 15(4), 2000, pp. 335-356
71. Clare, BW; Scozzafava, A; Briganti, F; Iorga, B; Supuran, CT
    Protease inhibitors. Part 2. Weakly basic thrombin inhibitors incorporating sulfonyl-aminoguanidine moieties as S1 anchoring groups: Synthesis and structure-activity correlations
    JOURNAL OF ENZYME INHIBITION
    
    B.W. Clare et al., "Protease inhibitors. Part 2. Weakly basic thrombin inhibitors incorporating sulfonyl-aminoguanidine moieties as S1 anchoring groups: Synthesis and structure-activity correlations", J ENZ INHIB, 15(3), 2000, pp. 235-264
72. Grines, CL; Kereiakes, D
    Antithrombotic therapy in the catheterization laboratory: interim analysisof the NICE trials
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    C.L. Grines e D. Kereiakes, "Antithrombotic therapy in the catheterization laboratory: interim analysisof the NICE trials", EUR H J SUP, 2(F), 2000, pp. F12-F15
73. Diet, F; Erdmann, E
    Thromboembolism in heart failure: who should be treated?
    EUROPEAN JOURNAL OF HEART FAILURE
    
    F. Diet e E. Erdmann, "Thromboembolism in heart failure: who should be treated?", EUR J HE FA, 2(4), 2000, pp. 355-363
74. Vogel, P
    Synthesis of rare carbohydrates and analogues starting from enantiomerically pure 7-oxabicyclo[2.2.1]heptyl derivatives ("naked sugars")
    CURRENT ORGANIC CHEMISTRY
    
    P. Vogel, "Synthesis of rare carbohydrates and analogues starting from enantiomerically pure 7-oxabicyclo[2.2.1]heptyl derivatives ("naked sugars")", CURR ORG CH, 4(5), 2000, pp. 455-480
75. Scatena, R
    Bivalirudin: a new generation antithrombotic drug
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    R. Scatena, "Bivalirudin: a new generation antithrombotic drug", EXPERT OP I, 9(5), 2000, pp. 1119-1127
76. Wallentin, L
    Low molecular weight heparin in unstable coronary artery disease
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    L. Wallentin, "Low molecular weight heparin in unstable coronary artery disease", EXPERT OP I, 9(3), 2000, pp. 581-592
77. Teng, MP; Catherwood, E; Melby, DP
    Cost effectiveness of therapies for atrial fibrillation - A review
    PHARMACOECONOMICS
    
    M.P. Teng et al., "Cost effectiveness of therapies for atrial fibrillation - A review", PHARMACOECO, 18(4), 2000, pp. 317-333
78. Sebastian, JL; Tresch, DD
    Use of oral anticoagulants in older patients
    DRUGS & AGING
    
    J.L. Sebastian e D.D. Tresch, "Use of oral anticoagulants in older patients", DRUG AGING, 16(6), 2000, pp. 409-435
79. Carlsson, J; Miketic, S; Dees, G; Haun, S; Cuneo, A; Tebbe, U
    Stroke prevention practices in patients with atrial fibrillation and pacemaker therapy - Evidence for under-use of anticoagulation
    EUROPACE
    
    J. Carlsson et al., "Stroke prevention practices in patients with atrial fibrillation and pacemaker therapy - Evidence for under-use of anticoagulation", EUROPACE, 2(2), 2000, pp. 115-118
80. Balcezak, TJ; Krumholz, HM; Getnick, GS; Vaccarino, V; Lin, ZQ; Cadman, EC
    Utilization and effectiveness of a weight-based heparin nomogram at a large academic medical center
    AMERICAN JOURNAL OF MANAGED CARE
    
    T.J. Balcezak et al., "Utilization and effectiveness of a weight-based heparin nomogram at a large academic medical center", AM J M CARE, 6(3), 2000, pp. 329-338
81. Watson, HR; Bergqvist, D
    Antithrombotic agents after peripheral transluminal angioplasty: a review of the studies, methods and evidence for their use
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
    
    H.R. Watson e D. Bergqvist, "Antithrombotic agents after peripheral transluminal angioplasty: a review of the studies, methods and evidence for their use", EUR J VAS E, 19(5), 2000, pp. 445-450
82. Schanbacher, CF; Bennett, RG
    Postoperative stroke after stopping warfarin for cutaneous surgery
    DERMATOLOGIC SURGERY
    
    C.F. Schanbacher e R.G. Bennett, "Postoperative stroke after stopping warfarin for cutaneous surgery", DERM SURG, 26(8), 2000, pp. 785-789
83. Iqbal, O; Messmore, H; Hoppensteadt, D; Fareed, J; Wehrmacher, T
    State-of-the-art review - Thrombolytic drugs in acute myocardial infarction
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    
    O. Iqbal et al., "State-of-the-art review - Thrombolytic drugs in acute myocardial infarction", CL APPL T-H, 6(1), 2000, pp. 1-13
84. Sotiriou, CG; Cheng, JWM
    Beneficial effects of statins in coronary artery disease - Beyond loweringcholesterol
    ANNALS OF PHARMACOTHERAPY
    
    C.G. Sotiriou e J.W.M. Cheng, "Beneficial effects of statins in coronary artery disease - Beyond loweringcholesterol", ANN PHARMAC, 34(12), 2000, pp. 1432-1439
85. Richter, GM; Palmaz, JC; Noeldge, G; Tio, F
    Blood flow and thrombus formation determine the development of stent neointima
    JOURNAL OF LONG-TERM EFFECTS OF MEDICAL IMPLANTS
    
    G.M. Richter et al., "Blood flow and thrombus formation determine the development of stent neointima", J LONG-TE E, 10(1-2), 2000, pp. 69-77
86. Carroll, WR; Esclamado, RM
    Ischemia/reperfusion injury in microvascular surgery
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    
    W.R. Carroll e R.M. Esclamado, "Ischemia/reperfusion injury in microvascular surgery", HEAD NECK, 22(7), 2000, pp. 700-713
87. Parnetti, L; Gallai, V
    Atrial fibrillation and stroke
    CEREBROVASCULAR DISEASES
    
    L. Parnetti e V. Gallai, "Atrial fibrillation and stroke", CEREB DIS, 10, 2000, pp. 40-41
88. Egbertson, MS; Bednar, B; Askew, BC; Bednar, RA; Brashear, K; Breslin, MJ; Duggan, ME; Fisher, TE; Halczenko, W; Hutchinson, JH; Ihle, N; Prugh, JD; Wai, JS; Gould, RJ; Hartman, GD
    Nonpeptide GPIIB/IIIA receptor antagonists. Part 21: C-6 flexibility and amide bond orientation are important factors in determining the affinity of compounds for activated or resting platelet receptors
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    
    M.S. Egbertson et al., "Nonpeptide GPIIB/IIIA receptor antagonists. Part 21: C-6 flexibility and amide bond orientation are important factors in determining the affinity of compounds for activated or resting platelet receptors", BIOORG MED, 10(17), 2000, pp. 1943-1948
89. Pacheco, RG; Vicente, CP; Zancan, P; Maurao, PAS
    Different antithrombotic mechanisms among glycosaminoglycans revealed witha new fucosylated chondroitin sulfate from an echinoderm
    BLOOD COAGULATION & FIBRINOLYSIS
    
    R.G. Pacheco et al., "Different antithrombotic mechanisms among glycosaminoglycans revealed witha new fucosylated chondroitin sulfate from an echinoderm", BL COAG FIB, 11(6), 2000, pp. 563-573
90. Bendz, B; Andersen, TO; Sandset, PM
    Dose-dependent release of endogenous tissue factor pathway inhibitor by different low molecular weight heparins
    BLOOD COAGULATION & FIBRINOLYSIS
    
    B. Bendz et al., "Dose-dependent release of endogenous tissue factor pathway inhibitor by different low molecular weight heparins", BL COAG FIB, 11(4), 2000, pp. 343-348
91. Costantini, V; Deveglia, R; Stabile, A; Nenci, GG
    Absorption and antithrombotic activity of unfractioned heparin after intraduodenal administration in rats
    BLOOD COAGULATION & FIBRINOLYSIS
    
    V. Costantini et al., "Absorption and antithrombotic activity of unfractioned heparin after intraduodenal administration in rats", BL COAG FIB, 11(1), 2000, pp. 7-13
92. Arnljots, B; Soderstrom, T; Ezban, M; Hedner, U
    Effect of locally-applied active site-blocked activated factor VII (ASIS) on experimental arterial thrombosis
    BLOOD COAGULATION & FIBRINOLYSIS
    
    B. Arnljots et al., "Effect of locally-applied active site-blocked activated factor VII (ASIS) on experimental arterial thrombosis", BL COAG FIB, 11, 2000, pp. S145-S148
93. Lilova, MI; Velkovski, IG; Velichkov, NI
    Budd-Chiari syndrome and inferior vena cava thrombosis in a nephrotic child
    PEDIATRIC NEPHROLOGY
    
    M.I. Lilova et al., "Budd-Chiari syndrome and inferior vena cava thrombosis in a nephrotic child", PED NEPHROL, 14(5), 2000, pp. 412-415
94. Cohen, M; Maritz, F; Gensini, GF; Danchin, N; Timerman, A; Huber, K; Gurfinkel, EP; White, H; Fox, KAA; Vittori, L; Le-Louer, V; Bigonzi, F
    The TETAMI trial: The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and of tirofiban versus placebo in thetreatment of acute myocardial infarction for patients not thrombolyzed: Methods and design
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    
    M. Cohen et al., "The TETAMI trial: The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and of tirofiban versus placebo in thetreatment of acute myocardial infarction for patients not thrombolyzed: Methods and design", J THROMB TH, 10(3), 2000, pp. 241-246
95. Fraga, AGM; Rodrigues, CR; de Miranda, ALP; Barreiro, EJ; Fraga, CAM
    Synthesis and pharmacological evaluation of novel heterotricyclic acylhydrazone derivatives, designed as PAF antagonists
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
    
    A.G.M. Fraga et al., "Synthesis and pharmacological evaluation of novel heterotricyclic acylhydrazone derivatives, designed as PAF antagonists", EUR J PH SC, 11(4), 2000, pp. 285-290
96. Brener, SJ
    Unfractionated and low-molecular-weight heparins in acute coronary syndromes: Current recommendations
    CLEVELAND CLINIC JOURNAL OF MEDICINE
    
    S.J. Brener, "Unfractionated and low-molecular-weight heparins in acute coronary syndromes: Current recommendations", CLEV CLIN J, 67(1), 2000, pp. 59-65
97. Ganz, DA; Glynn, RJ; Mogun, H; Knight, EL; Bohn, RL; Avorn, J
    Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism
    JOURNAL OF GENERAL INTERNAL MEDICINE
    
    D.A. Ganz et al., "Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism", J GEN INT M, 15(11), 2000, pp. 776-781
98. Segal, JB; McNamara, RL; Miller, MR; Kim, N; Goodman, SN; Powe, NR; Robinson, KA; Bass, EB
    Prevention of thromboembolism in atrial fibrillation - A meta-analysis of trials of anticoagulants and antiplatelet drugs
    JOURNAL OF GENERAL INTERNAL MEDICINE
    
    J.B. Segal et al., "Prevention of thromboembolism in atrial fibrillation - A meta-analysis of trials of anticoagulants and antiplatelet drugs", J GEN INT M, 15(1), 2000, pp. 56-67
99. Douketis, JD; Crowther, MA; Cherian, SS
    Perioperative anticoagulation in patients with chronic atrial fibrillationwho are undergoing elective surgery: Results of a physician survey
    CANADIAN JOURNAL OF CARDIOLOGY
    
    J.D. Douketis et al., "Perioperative anticoagulation in patients with chronic atrial fibrillationwho are undergoing elective surgery: Results of a physician survey", CAN J CARD, 16(3), 2000, pp. 326-330
100. Baggio, D; Madore, F; Lalonde, G
     Oral anticoagulant therapy for heart disease: Results in actual cardiologypractice
     CANADIAN JOURNAL OF CARDIOLOGY
     
     D. Baggio et al., "Oral anticoagulant therapy for heart disease: Results in actual cardiologypractice", CAN J CARD, 16(2), 2000, pp. 153-161